Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Planning for retirement is crucial for financial security. Find out when to start this important journey and set yourself up for success.
26,825 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A 2023 Vanderbilt incident sparked a modern AI writing debate, echoing a long history of ghostwriting and the ethics ...
Meta plans to cut about 8,000 jobs as part of a broader AI infrastructure push. The move shifts investor attention to...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
Applied Materials is set to report Q2 results after the close, as investors weigh demand signals for AI chips and adv...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
ON Semiconductor climbs to fresh highs in 2026 as AI data-center demand and GaN power tech power a strong cash flow-l...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
U.S. investors will soon access perpetual futures, a cornerstone of the hottest crypto products world, under a new re...
Bitcoin breached a critical price point, fueling renewed selling across crypto markets. Analysts warn that further de...
Ukraine’s drone strikes on Russian supply lines intensify funding strains as deficits widen and reserves shrink. This...
Dell Technologies pivots from PC maker to AI infrastructure leader, as it visits higher backlog levels and raises rev...